Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women.

Chan KY, Liu W, Long JR, Yip SP, Chan SY, Shu XO, Chua DT, Cheung AN, Ching JC, Cai H, Au GK, Chan M, Foo W, Ngan HY, Gao YT, Ngan ES, Garcia-Barceló MM, Zheng W, Khoo US.

J Med Genet. 2009 Jan;46(1):32-9. doi: 10.1136/jmg.2007.057174.

2.

Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer.

Bielinska B, Gaj P, Kluska A, Nowakowska D, Balabas A, Dabrowska M, Niwinska A, Gruchota J, Zub R, Skasko E, Steffen J, Ostrowski J, Siedlecki JA.

Fam Cancer. 2013 Dec;12(4):691-8. doi: 10.1007/s10689-013-9647-6.

PMID:
23657760
3.

A BRCA1 promoter variant (rs11655505) and breast cancer risk.

Verderio P, Pizzamiglio S, Southey MC, Spurdle AB, Hopper JL, Chen X, Beesley J; Australian Ovarian Cancer Study Group KConFab., Schmutzler RK, Engel C, Burwinkel B, Bugert P, Ficarazzi F, Manoukian S, Barile M, Wappenschmidt B, Chenevix-Trench G, Radice P, Peterlongo P.

J Med Genet. 2010 Apr;47(4):268-70. doi: 10.1136/jmg.2009.073544.

PMID:
20413709
4.

Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.

Hasan TN, Leena Grace B, Shafi G, Syed R.

Clin Transl Oncol. 2013 Jul;15(7):555-62. doi: 10.1007/s12094-012-0968-y.

PMID:
23263908
5.

Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.

Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W, Shao ZM.

Hum Mol Genet. 2009 Jul 1;18(13):2502-17. doi: 10.1093/hmg/ddp171.

6.

[Effect of R264C polymorphism in CYP19A1 gene on BRCA1/2-negative hereditary breast cancer from Shanghai population of China].

Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Apr;23(2):181-3. Chinese.

PMID:
16604491
7.

Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.

Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1148-52.

8.

Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.

Ling H, Li S, Wu Y, Zheng YZ, Qiao F, Yao L, Cao ZG, Ye FG, Wu J, Hu X, Wang B, Shao ZM.

Oncotarget. 2016 Mar 1;7(9):9759-72. doi: 10.18632/oncotarget.7112.

9.

Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.

Kwong A, Ng EK, Wong CL, Law FB, Au T, Wong HN, Kurian AW, West DW, Ford JM, Ma ES.

PLoS One. 2012;7(9):e43994. doi: 10.1371/journal.pone.0043994.

10.

Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population.

Zhou P, Du LF, Lv GQ, Yu XM, Gu YL, Li JP, Zhang C.

Breast Cancer Res Treat. 2011 Jul;128(2):527-34. doi: 10.1007/s10549-011-1365-x.

PMID:
21293922
11.

A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.

Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):955-60.

12.

Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India.

Kapahi R, Guleria K, Sambyal V, Manjari M, Sudan M, Uppal MS, Singh NR.

Tumour Biol. 2014 Nov;35(11):11171-81. doi: 10.1007/s13277-014-2404-0.

PMID:
25106408
13.

Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.

Wang L, Li D, Fu Z, Li H, Jiang W, Li D.

BMC Cancer. 2007 Sep 10;7:173.

14.

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.

Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL; Ontario Cancer Genetics Network., Thomassen M, Gerdes AM, Caligo MA, Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg Å, Karlsson P, Askmalm MS, Bustinza GB; SWE-BRCA Collaborators., Nathanson KL, Domchek SM, Rebbeck TR, Benítez J, Hamann U, Rookus MA, van den Ouweland AM, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P, Gille HJ; HEBON.; EMBRACE., Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Paterson J, Eason J, Godwin AK, Remon MA, Moncoutier V, Gauthier-Villars M, Lasset C, Giraud S, Hardouin A, Berthet P, Sobol H, Eisinger F, Bressac de Paillerets B, Caron O, Delnatte C; GEMO Study Collaborators., Goldgar D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB; Breast Cancer Family Registry., Singer CF, Dressler AC, Tea MK, Hansen TV, Johannsson O, Piedmonte M, Rodriguez GC, Basil JB, Blank S, Toland AE, Montagna M, Isaacs C, Blanco I, Gayther SA, Moysich KB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Ding YC, Couch FJ, Wang X, Peterlongo P, Manoukian S, Bernard L, Radice P, Easton DF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D, Mazoyer S, Sinilnikova OM; Consortium of Investigators of Modifiers of BRCA1/2..

Hum Mol Genet. 2011 Dec 1;20(23):4732-47. doi: 10.1093/hmg/ddr388.

15.

Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.

de Bruin MA, Kwong A, Goldstein BA, Lipson JA, Ikeda DM, McPherson L, Sharma B, Kardashian A, Schackmann E, Kingham KE, Mills MA, West DW, Ford JM, Kurian AW.

Fam Cancer. 2012 Sep;11(3):429-39. doi: 10.1007/s10689-012-9531-9.

PMID:
22638769
16.

Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population.

Kong F, Liu J, Liu Y, Song B, Wang H, Liu W.

J Exp Clin Cancer Res. 2010 Jun 17;29:72. doi: 10.1186/1756-9966-29-72.

17.

Significance of rs1271572 in the estrogen receptor beta gene promoter and its correlation with breast cancer in a southwestern Chinese population.

Chen L, Liang Y, Qiu J, Zhang L, Chen X, Luo X, Jiang J.

J Biomed Sci. 2013 May 28;20:32. doi: 10.1186/1423-0127-20-32.

18.

A genetic variant in the promoter of APE1 gene (-656 T>G) is associated with breast cancer risk and progression in a Chinese population.

Kang H, Dai Z, Ma X, Ma L, Jin Y, Liu X, Wang X.

Gene. 2013 Nov 15;531(1):97-100. doi: 10.1016/j.gene.2013.08.052.

PMID:
23994194
19.

The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population.

Hu M, Zheng J, Zhang L, Jiang L, You Y, Jiang M, Li H.

DNA Cell Biol. 2012 Jul;31(7):1167-73. doi: 10.1089/dna.2011.1586.

20.

BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women.

Liu L, Fang Y, Fan J, Hu J, Xu X, Jin X, Wang X, Deng M, Wang J, Liu W.

Chin Med J (Engl). 2014;127(11):2012-5.

Items per page

Supplemental Content

Support Center